ERBB2 and neoplasm: We then compared the CNA profiles from the CTC samples and synchronous bulk tumor and found mostly concordant profiles for the patients with TNBC (#1) and HER2+ tumors (#2), with correlations of CNA profiles between CTC samples ranging from 63 to 94%.